On Wednesday 1 November 2017 a mini symposium was organised to mark the retirement of Dr Christine Gispen-de Wied, manager of the MEB Programme Office Science. Although Christine is retiring she is going to continue to be involved with the Medicines Evaluation Board (MEB) for 1 day a week in order to complete a number of research projects.
Various speakers helped to illustrate her career at the MEB. Drs Hugo Hurts, MEB director, proudly talked about Christine's career, first and foremost because the development and the importance of Regulatory Science has now been put firmly on the map.
In a three-part speech, former MEB chairman Prof. Bert Leufkens referred to her dedication as she has made a huge contribution to the development of the MEB's Regulatory Science programme. Interviews with both of them are included in the 3rd editon of the Regulatory Science Magazine.
Prof.dr Fernando de Andres-Trelles of the Spanish medicines agency AEMPS gave a presentation about extrapolation of CNS-indicators of adults to children. Extrapolation to children of drugs for psychiatric disorders is an issue in Regulatory Science.
Dr Tamar Wohlfarth spoke about psychiatry, particularly concerning the researches which she had done together with Christine on terms of big data which is built by the MEB out of students / studiegegevens of pharmaceutial companies. These data have led to many publications and some promotions of MEB employees.
Finally, dr Abby Yu and dr Peter van Meer highlighted Christine’s work for the implementation of the Programme Science Office. That is why we now have a stable Programme of regulatory research with PhDs and students, a result to be proud of!
Below you find a photo impression of the farewell symposium of Christine Gispen-de Wied.
